Latest news
- Home
- Press Room
- Latest News
Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.
COVID-19 - Unprecedented research combining genomics and artificial intelligence
June 17, 2020
Génome Québec is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications.
Génome Québec commends the federal government’s contribution to research
Apr. 23, 2020
The President and CEO of Génome Québec, Daniel Coderre, applauds Ottawa’s decision to invest $40 million in research on sequencing the genomes of the virus and of patients to better understand the behaviour and evolution of the virus, as well as the different immune reactions by patients. The initiative is part of a $1 billion package of measures announced today by Prime Minister Justin Trudeau in support of medical research into COVID-19.
Congratulations to Guy Rouleau, recipient of a Gairdner Award
Apr. 3, 2020
Dr. Guy Rouleau received the Canada Gairdner Wightman Award 2020 for his outstanding work on identifying and elucidating the general mechanisms of neurological and psychiatric diseases, such as ALS (amyotrophic lateral sclerosis), autism and schizophrenia.
Marc Bergeron Appointed Vice President, Finance
Mar. 31, 2020
Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Marc Bergeron to the position of Vice President, Finance, starting April 1, 2020. Mr. Bergeron will be taking over from Claude Lamarre, who is retiring after thirteen years of service.
COVID-19 – A New Initiative from the Québec Research Sector
Mar. 26, 2020
As part of the initiatives put forward to find solutions to the COVID-19 pandemic, the Fonds de recherche du Québec and Génome Québec have tasked a group of researchers with establishing the Québec COVID Biobank.
Génome Québec activities remains operational
Mar. 19, 2020
Génome Québec is closely monitoring the development of the situation caused by COVID-19 and has taken all the necessary measures to reduce the risk of transmission. The safety of our employees and partners is an absolute priority. All travel has been cancelled; employees are all working from home and the largest gatherings that cannot be held remotely have been postponed. We are operating in strict compliance with the guidelines issued by the government.
Canada SynBio 2020 is postponed
Mar. 19, 2020
Given the situation around COVID-19 and actions being taken by the Canadian, Quebec and Ontario governments, the Canada SynBio conference, which was supposed to take place on June 3rd in Montreal, is postponed. The health and wellbeing of the attendees, speakers, staff and general public remains the top priority.
Québec Government reiterates its confidence in Génome Québec
Mar. 12, 2020
The budget presented on March 10, by the Minister of Finance, Éric Girard, sends a very encouraging message to the research and innovation community, particularly in life sciences, with many indications in the budget pointing to a solid commitment to knowledge.
Génome Québec celebrates its 20th anniversary
Mar. 5, 2020
Génome Québec will celebrate its 20th anniversary in 2020.
To mark the occasion, we are pleased to present our new logo.
Ovarian and endometrial cancers: $ 6M closer to a lifesaving screening pap test
Mar. 2, 2020
Genome Québec is happy to report that Dr. Lucy Gilbert’s research team will receive $ 6.24 million in Genomics Applications Partnership Program (GAPP) funding grant to finalize the development of DOvEEgene (Detecting Ovarian and Endometrial cancers Early using genomics)—a screening test that could save thousands of lives every year in Canada and millions of lives worldwide. To learn more about the study, click here.